Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
INDY
AOB1261
Chemical Name: (1Z)-1-(3-ethyl-5-hydroxy-1,3-benzothiazol-2(3H)-ylidene)-2-propanone;
CAS No:1169755-45-6
899 Items
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $12.75 | Total: $63.75 |
| 1 | 10 | $10.80 | Total: $108.00 |
| 1 | 25 | $9.15 | Total: $228.75 |
| 1 | 50 | $7.80 | Total: $390.00 |
| 1 | 100 | $6.75 | Total: $675.00 |
Overview
Novel potent ATP-competitive Dyrk1A inhibitor
Chemical Properties
| Molecular Formula | C12H13NO2S |
| Molecular Weight | 235.3 |
| CAS Numbers | 1169755-45-6 |
| Solubility | DMSO 20 mg per mL |
| Purity | 98% by HPLC |
| IUPAC/Chemical Name | 1Z-(3-ethyl-5-hydroxy-2(3H)-benzothiazolylidene)-2-propanone |
| InChl Key | GCSZJMUFYOAHFY-SDQBBNPISA-N |
| InChl Code | InChI=1S/C12H13NO2S/c1-3-13-10-7-9(15)4-5-11(10)16-12(13)6-8(2)14/h4-7,15H,3H2,1-2H3/b12-6- |
| SMILES Code | OC1=CC=C2C(N(CC)/C(S2)=C/C(C)=O)=C1 |
Storage and Handling
0°C (short term), -20°C (long term), desiccated
References
1) Ogawa, Y., Nonaka, Y., Goto, T., et al. Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A. Nat. Commun. 1:86, (2010).
2) Wang, P., Alvarez-Perez, J.C., Felsenfeld, D.P., et al. A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat. Med. 21(4), 383-388 (2015).
